Transcriptomic Profiling Identifies CD8(+ )T Cells in the Brain of Aged and Alzheimer?s Disease Transgenic Mice as Tissue-Resident Memory T Cells.

Altendorfer, B; Unger, MS; Poupardin, R; Hoog, A; Asslaber, D; Gratz, IK; Mrowetz, H; Benedetti, A; de Sousa, DMB; Greil, R; Egle, A; Gate, D; Wyss-Coray, T; Aigner, L. J Immunol. 2022 Oct 1;209(7):1272-1285. doi: 10.4049/jimmunol.2100737. Epub 2022 Aug 31.

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordi-nated by the AGMT Study Group.

Gampenrieder, SP; Dezentjé, V; Lambertini, M; de Nonneville, A; Marhold, M; Le Du, F; Cortés Salgado, A; Alpuim Costa, D; Vaz Batista, M; Chic Ruché, N; Tinchon, C; Petzer, A; Blondeaux, E; Del Mastro, L; Targato, G; Bertucci, F; Gonçalves, A; Viret, F; Bartsch, R; Mannsbart, C; Deleuze, A; Robert, L; Saa-vedra Serrano, C; Gion Cortés, M; Sampaio-Alves, M; Vitorino, M; Pecen, L; Singer, C; Harbeck, N; Rinnerthaler, G; Greil, R. ESMO Open. 2022 Dec 21;8(1):100747. doi: 10.1016/j.esmoop.2022.100747. Online ahead of print.

How We Treat Localized Rectal Cancer-An Institutional Paradigm for To-tal Neoadjuvant Therapy.

Roeder, F; Gerum, S; Hecht, S; Huemer, F; Jäger, T; Kaufmann, R; Klieser, E; Koch, OO; Neureiter, D; Emmanuel, K; Sedlmayer, F; Greil, R; Weiss, L. Cancers (Basel). 2022 Nov 21;14(22):5709. doi: 10.3390/cancers14225709.

An early glimpse at azacitidine plus venetoclax for myelodysplastic syndromes.

Pleyer, L; Sekeres, MA. Lancet Haematol. 2022 Oct;9(10):e714-e716. doi: 10.1016/S2352-3026(22)00252-6. Epub 2022 Sep 2.

Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperati-ve chemotherapy with the FLOT protocol.

Huemer, F; Hecht, S; Scharinger, B; Schlintl, V; Rinnerthaler, G; Schlick, K; Heregger, R; Melchardt, T; Wimmer, A; Mühlbacher, I; Koch, OO; Neureiter, D; Klieser, E; Seyedinia, S; Beheshti, M; Greil, R; Weiss, L. J Cancer Res Clin Oncol. 2022 Jul 21. doi: 10.1007/s00432-022-04096-w. Online ahead of print.

The influence of pancreatic regression characteristics on outcome of neoadjuvant treated pancreatic cancer in two Austrian university centres.

Neumayer, B; Neureiter, D; Klieser, E; Huemer, F; Weiss, L; Greil, R; Djanani, A; Oberhuber, G; Schlick, K. Virchows Archiv. 2022; 481(Supplement 1):S135-S135.-34th European Congress of Pathology; 03.-07.09.2022; Basel.

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.

Moyo, TK; Mendler, JH; Itzykson, R; Kishtagari, A; Solary, E; Seegmiller, AC; Gerds, AT; Ayers, GD; Dezern, AE; Nazha, A; Valent, P; van de Loosdrecht, AA; Onida, F; Pleyer, L; Cirici, BX; Tibes, R; Geissler, K; Komrokji, RS; Zhang, J; Germing, U; Steensma, DP; Wiseman, DH; Pfeilstoecker, M; Elena, C; Cross, NCP; Luebbert, M; Mesa, RA; Sanz, GF; Platzbecker, U; Patnaik, MM; Padron, E; Santini, V; Fenaux, P; Savona, MR; Kiladjian, JJ; Montalban-Bravo, G. BMC Cancer. 2022 Sep 24;22(1):1013. doi: 10.1186/s12885-022-10073-w.

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.

Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grunberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R. Wien Klin Wochenschr.2022 Oct;134(19-20):683-692. doi: 10.1007/s00508-022-02082-3. Epub 2022 Sep 23.

Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+/ HR+ early breast cancer (eBC).

Harbeck, N; Wrobel, D; Zaiss, M; Guth, D; Distelrath, A; Terhaag, J; Lorenz, A; Bartsch, R; Breitenstein, U; Schwitter, M; Balic, M; Jackisch, C; Muller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinkothe, T; Luftner, D. ANN ONCOL. 2022; 33: S157-S157.

CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).

Folprecht, G; Reinacher-Schick, A; Weitz, J; Lugnier, C; Kraeft, AL; Wisser, S; Aust, DE; Weiss, L; von Bubnoff, N; Kramer, M; Thiede, C; Tannapfel, A. Clin Colorectal Cancer. 2022 Jun;21(2):170-174. doi: 10.1016/j.clcc.2021.09.005. Epub 2021 Sep 15.